|
Back
Gas Discharge
Visualization to Assess Bioenergy for Medical Applications
Principal Investigator: Clair A. Francomano, MD, Chief, Human Genetics and
Integrative Medicine, Laboratory of Genetics, National Institute of Aging
Affiliations: National Institutes of Health; Johns Hopkins University
Background: Many systems of healing use the concept of a bioenergy
that runs through the human body and plays a pivotal role in an
individuals health. Though there are tools that purport to measure these
fields, most data have not been obtained in rigorous scientific fashion or
published in international peer-review journals of repute. Clinical
studies to evaluate the validity of such devices require clinical
facilities and investigators with
expertise in the regulatory and design issues inherent in such research.
The Gas Discharge Visualization [GDV] instrument was invented by
Konstantin Korotkov in 1999. The device is a culmination of previous work
that photographs patterns of light coronas in close proximity to objects
including humans, with computerized systems for analysis of these
discharges. It is now appropriate to evaluate GDV rigorously on human
subjects with known medical diagnoses.
Hypotheses: 1) There is an energy field surrounding each human being,
which is detectable and quantifiable by existing instruments; 2)
alterations in the human energy field correlate with medical diagnoses as
established by traditional Western approaches and in some instances
predate the medical diagnoses.
Methods and materials: Specific clinical research protocols will be
created to test the GDV and determine its correlation with known medical
diagnoses. Approvals from Human Use Review Committees and the Food and
Drug Administration for conduct of the research will be obtained.
Anticipated results: If successful, this research will demonstrate the
first scientifically objective method for directly measuring human bioenergy.
Relationship to SIIB mission and healing: The presence of a human
energy field is an essential component of many nonwestern systems of
healing. GDV might become a bonafide measurement device of bioenergy,
allowing the use of non-molecular non-thermal informational signals in
healing. The planned research would meet FDA approval thereby allowing GDV
to be used in clinical research studies and eventually clinical practice.
|